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Abstract: We present a method for using longitudinal data to classify
individuals into clinically-relevant population subgroups. This is achieved
by treating “subgroup” as a categorical covariate whose value is unknown
for each individual, and predicting its value using mixtures of models that
represent “typical” longitudinal data from each subgroup. Under a nonlinear
mixed effects model framework, two types of model mixtures are presented,
both of which have their advantages. Following illustrative simulations, lon-
gitudinal viral load data for HIV-positive patients is used to predict whether
they are responding – completely, partially or not at all – to a new drug
treatment.
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1. INTRODUCTION
For a variety of reasons – some known, some not – different patients respond dif-
ferently to the same drug treatment. For certain patients, a drug does what it was
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prescribed to do: kill bacteria, reduce blood pressure, decrease viral load, etc., but
for others, the drug may be toxic or ineffective. When we collect response data on
patients undergoing a treatment, it is useful to try to find patients for which the
treatment is ineffective, and thus suggest modifications. We are particularly inter-
ested here in longitudinal response data in a population; the methods we present
are generally applicable to this type of data.
The real-world example that motivates the approach is longitudinal HIV viral
load data. For HIV-positive patients on a given drug regime, the evolution of
the viral load in the blood can be measured over time. For some patients, the drug
regime is ineffective and the viral load does not consistently drop; we call these non-
responders, and it is of interest to detect them and provide alternative – hopefully
more effective – treatments. Other patients react favourably to the treatment and
the viral load drops to undetectable levels and stays there for a long period of time;
these are called responders. Yet another group – rebounders – show an initial drop
in viral load followed by an increase back towards the initial high viral load. They
too will eventually require an alternative treatment.
Our goal is to use longitudinal data to infer the efficacy of the treatment, i.e.,
infer whether each patient is a non-responder, responder, rebounder or, as we will
explain, some mixture of the above. In order to do this, we first model longitudinal
HIV viral load data using recent additions to the nonlinear mixed-effects model
(NLMEM) framework. Then, we extract relevant posterior probabilities or indi-
vidual parameters to infer patient status. We now briefly introduce the NLMEM
framework and model mixtures. To avoid potential confusion, note that mixed-
effects models and model mixtures are not the same thing.
NLMEM – a special case of mixed-effects models – are statistical models which
use both fixed and random effects in their construction (see [3,10,21,23] for more
details). The model structure is hierarchical. At a first level, each individual has
their own parametric regression model, known as the structural model, each identi-
cally defined up to a set of unknown individual parameters. At a second level, each
set of individual parameters is assumed to be randomly drawn from some unknown
population distribution. These models are particularly useful in population studies
(e.g., population pharmacology – see [24]) where data is available for many individ-
uals. Two types of variability are involved: intra- and inter -subject. We attempt
to explain the latter using known fixed-effects (covariates) such as weight, blood
type, etc. The non-explained part of the inter-subject variability is then modeled
using random effects.
The introduction of a categorical covariate (e.g., sex, blood type, etc.) into
such a model supposes that the population can be divided into subpopulations with
respect to that covariate. However, there may be a categorical covariate which
interests us but whose value is unknown for all individuals, such as the covariate
“patient status” which interests us here. In this case, part of the goal becomes to
infer the value of this covariate for each individual as part of the modeling process.
One way to do this is to introduce model mixtures. There exist several types of
model mixture which are useful in the context of mixed effects models; we will
focus on two here:
• Between-Subject Model Mixtures (BSMM) assume that each individual’s lon-
gitudinal data follows one of M “base” models, but we do not necessarily
know a priori which one. Individual i thus has a label zi = m ∈ {1, . . . ,M}
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referring to the model that is supposed to have generated it. If the zi are
known, they can be treated as categorical covariates. We will show how to
deal with the more challenging case of when they are unknown. Furthermore,
for this zi unknown case, we will show how to extract a posteriori estimates of
the probability that each individual was generated by each of the base mod-
els; this will be used to predict which type of patient we have: non-responder,
responder or rebounder. We note that BSMM were introduced as an example
of a more general framework in [11] but were not developed further there.
• Within-Subject Model Mixtures (WSMM) make the hypothesis that the model
mixture occurs within each individual. In the HIV example, this means that
we consider that each patient is partially a non-responder, partially a respon-
der and partially a rebounder. This is perhaps more biologically plausible
than BSMMs in the sense that each individual’s response may be due to their
own particular combination of virus strains, cell populations, etc. Within the
NLMEM framework, this means including individual “model proportion” pa-
rameters into the model and having to estimate them along with the other
parameters of the NLMEM. It turns out that this does not require any math-
ematical extensions to a typical NLMEM. But as will be seen in the HIV
example, we can use the estimated proportions to help categorize patients,
especially those who do not naturally fall into one of the three “typical” cat-
egories.
BSMM and WSMM are new approaches in the context of NLMEM. We refer
the reader to [1,12,13,15,16] for general details on mixture models in a standard
context. We note also that there are fully Bayesian approaches to similar types of
problems, in particular Bayesian nonparametric ones (see [7] for more details).
The paper is structured as follows. We introduce BSMMs in the NLMEM frame-
work and calculate their log-likelihood, before briefly presenting WSMMs; they
require no new mathematical framework. We then describe how to perform maxi-
mum likelihood estimation (MLE) for BSMMs using the Stochastic Approximation
Expectation Maximization (SAEM) algorithm [4]. SAEM is implemented in the
Monolix software and can be widely applied to various data types and real-life
scenarios [2,6,9,18,22]. Next, we present an example for a simple BSMM case, and
then a simulated example for mixtures of two models in the both the BSMM and
WSMM cases. The simulations illustrate the quality of the parameter estimation
of both methods and also their classification performance, i.e., how well they “pre-
dict” which model was used to generate each individual’s data (in the BSMM case)
and which model represented the biggest proportion (in the WSMM case). This is
followed by a comprehensive modeling of HIV treatment response longitudinal data
from a cohort of 578 patients using both BSMM and WSMM and a comparison of
the quality and practical usefulness of each method. A discussion follows.
2. MODELS AND METHODS
2.1. Between-Subject Model Mixtures
Between-subject model mixtures (BSMMs) are a special case of NLMEMs that
assume that the structural model is a mixture of M different structural models and
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can be written, in the case of a continuous response, as:
yij =
M∑
m=1
1{zi=m}
(
fm (xij ;ψi) + gm (xij ;ψi, ξ) εij
)
, (1)
where
• yij ∈ R denotes the jth observation of the ith individual, 1 ≤ i ≤ N and
1 ≤ j ≤ ni.
• N is the number of individuals and ni the number of observations of the ith
individual.
• xij is a vector of regression variables (for longitudinal data, xij will generally
be time tij).
• ψi is the d-vector of individual parameters of individual i. We assume that
all the ψi are drawn from the same population distribution and are defined
as Gaussian transformations:
ψi = h(µ, ci, ηi), (2)
where h is a function which describes the covariate model, µ a vector of fixed-
effects, ci a vector of known covariates, ηi ∼i.i.d N (0,Σ) a vector of random
effects and Σ the inter-individual variance-covariance matrix.
• zi ∈ {1, . . . ,M} represents the (un)known group to which belongs the individ-
ual i. The proportion of individuals in group m is given by pim = P (zi = m)
with
∑M
m=1 pim = 1.
• εij ∼ N (0, 1) are the residual errors, and are independent of individual pa-
rameters ψi.
• fm for m = 1, . . . ,M are functions defining structural models in each group.
• gm for m = 1, . . . ,M are functions defining the (possibly heteroscedastic)
residual error model. We will consider here error models of the form gm =
a+ b fm.
Furthermore, let θ = (µ,Σ, ξ, pi1, . . . , piM ) represent the complete set of popula-
tion parameters.
BSMMs are particularly relevant in the domain of population pharmacology if
we are aiming to distinguish between different classes of response to the same treat-
ment. For example, if we can effectively model each class of longitudinal response
data (specific mathematical function with parameters, etc.), a posteriori estima-
tion of the label zi for each individual leads to being able to assign each to a given
“typical” response. We shall see later in the real HIV data that classes such as “non-
responder”, “responder”, and “rebounder” could be used to categorize individuals’
responses in this application.
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2.2. Log-Likelihood of Between-Subject Model Mixtures
In this section, we briefly recall the initial exposition and notation in [11] for the
log-likelihood of mixture models in general; it will be useful in the following. The
complete data is noted (y, ψ, z) with y the observed data and (ψ, z) the unobserved
data. For subject i, the log-likelihood of the complete data is
L (yi, ψi, zi; θ) =
M∑
m=1
1zi=m (Lm (yi, ψi; θ) + logP (zi = m)) , (3)
where Lm (yi, ψi; θ), the log-likelihood of pairs of variables (yi, ψi) in group Gm :=
{i, 1 ≤ i ≤ N such that zi = m} , is given by Lm (yi, ψi; θ)=LY,m (yi|ψi; ξ)+Lψ(ψi;
µ, Σ). The right-hand side terms are simple to calculate. Lm is assumed to belong
to the exponential family, i.e., there exists a function ψ of θ and a minimal sufficient
statistic T (yi, ψi) such that Lm (yi, ψi; θ) = 〈T (yi, ψi) , θ〉 − ψ (θ) .
In what follows, we will note P (zi = m) as pim or piim for “proportion” for
respectively BSMM or WSMM. We have that
L (yi, ψi, zi; θ) =
M∑
m=1
1zi=m (〈T (yi, ψi) , θ〉+ log pim − ψ (θ)) .
The likelihood of the complete data also belongs to the exponential family as
it can be written L (y, ψ, z; θ) = 〈S (y, ψ, z) , θ〉 − ψ (θ) , where the mth row of S is
given by (
n∑
i=1
1zi=m ,
n∑
i=1
1zi=mT (yi, ψi)
)
.
We will show later that this representation of the log-likelihood is helpful for
implementing stochastic EM-like algorithms for the BSMM case.
2.3. Within-Subject Model Mixtures
It may be too simplistic to assume that each individual is represented by only one
well-defined model from the mixture. For instance, in a pharmacological setting
there may be subpopulations of cells, viruses (etc.) within each patient that re-
act differently to a drug treatment. In this case, it makes sense to consider that
the mixture of models happens within each individual. Such within-subject model
mixtures (WSMMs) therefore require additional vectors of individual parameters
pii = (pii1, . . . piiM ) representing proportions of the M models within each individual
i. These vectors are supposed independent of ψ, and naturally sum to 1 for each
individual. Using the same notation as Section 2.1, observations are modeled by:
yij =
M∑
m=1
piim (fm (xij ;ψi) + gm (xij ;ψi, ξ) εij) . (4)
Since there are no latent categorical covariates, WSMMs actually fall under the
framework of classical NLMEMs. Thus, no further specific methodology needs to
be developed, and we refer to [4,8] for the standard treatment.
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3. MAXIMUM LIKELIHOOD ESTIMATION ALGORITHMS
FOR BETWEEN-SUBJECT MODEL MIXTURES
A method such as the Stochastic Approximation EM (SAEM) algorithm [4] needs
to be used to replace the E-step of the EM algorithm in the NLMEM framework.
The stochastic step of SAEM is performed in practice using an MCMC proce-
dure. SAEM has been successfully applied to a wide number of data types and
real-life situations including bioequivalence crossover trials [6], estimation of popu-
lation pharmacokinetic-pharmacodynamic viral dynamics parameters [2], longitudi-
nal ordered categorical data [20], population models for count data [19] and group
comparison tests in longitudinal data analysis [18].
We now develop this technique in the case of BSMMs. Iteration k consists of a
number of MCMC iterations with p(ψ, z|y; θ(k)) as the stationary distribution. More
precisely, the Gibbs algorithm is combined with the Metropolis-Hastings algorithm,
with various proposal kernels. Here, the N subjects are assumed to be independent
and the same procedure is used for each of the N subjects.
For subject i, draw z
(k)
i ∈ {1, . . . ,M} from the multinomial distribution
MM
 pi
(k−1)
m pm
(
yi, ψ
(k−1)
i ; θ
(k−1)
)
M∑
r=1
pi
(k−1)
r pr
(
yi, ψ
(k−1)
i ; θ
(k−1)
)

m=1,...,M
.
A first possible kernel uses the marginal distribution p(ψi; ci, θ
(k)) for generating
a candidate ψci ; more precisely, ηi ∼ N
(
0,Σ(k)
)
and ψci is as in (2). The probability
of acceptance, i.e., the probability to move from ψi to ψ
c
i , becomes
α (ψi, ψ
c
i ) = min
1, p
(
y|ψci , z(k)i ; θ(k)
)
p
(
y|ψi, z(k)i ; θ(k)
)
 .
A random walk can also be used as a possible kernel: ψci ∼ N
(
ψ(k−1),Ω
)
.
The diagonal matrix Ω can be adaptively adjusted to get a chosen acceptance rate.
Setting different elements of the diagonal of Ω to 0 during iterations can be done
to use different directions. The probability of acceptance is
α (ψi, ψ
c
i ) = min
1, p
(
y, ψci , z
(k)
i ; θ
(k)
)
p
(
y, ψi, z
(k)
i ; θ
(k)
)
 .
For details on how to choose parameters such as the number of iterations of the
MCMC procedure during the simulation step, the step-size sequence (δk), etc., we
refer the reader to [11].
We remark that this version of SAEM for BSMMs is now implemented in the
Monolix software.
BSMM Example. In order to illustrate MLE for the BSMM model, let us con-
sider a simple example. Suppose first that we have a constant residual model
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gm (xij ;ψi, ξ) = a. Then, the conditional log-likelihood of the observations in the
group Gm is:
LY,m (yi|ψi; ξ) = − 1
2a2
ni∑
j=1
(yij − fm (xij , ψi))2 − ni log (a)− ni
2
log (2pi) .
Furthermore, assuming a Gaussian distribution without covariates (i.e., ψi =
µ+ ηi) for individual parameters, the likelihood of the individual parameters is
Lψ (ψi;µ,Σ) = −1
2
(ψi − µ)′ Σ−1 (ψi − µ)− d
2
log (2pi)− 1
2
log (|Σ|) .
In the first step of iteration k, we must approximate the following minimal
sufficient statistics:
sk,1,m = sk−1,1,m + δk
(
N∑
i=1
1
z
(k)
i =m
− sk−1,1,m
)
sk,2 = sk−1,2 + δk
(
N∑
i=1
ψ
(k)
i − sk−1,2
)
sk,3 = sk−1,3 + δk
(
N∑
i=1
ψ
(k)
i ψ
(k)
i
′ − sk−1,3
)
sk,4 = sk−1,4 + δk
∑
i,j,m
1
z
(k)
i =m
(
yij − fm
(
xij , ψ
(k)
i
))2
− sk−1,4
 .
Then, in the M-step, we update parameters according to:
pi(k)m =
sk,1,m
N
µ(k) =
sk,2
N
Σ(k) =
sk,3
N
−
(sk,2
N
)(sk,2
N
)′
a(k) =
√
sk,4∑N
i=1 ni
.
3.1. Estimation of Individual Parameters
The overall goal of this paper is not to provide complicated viral dynamics models
(ordinary differential equations, etc.) but rather to show how the model mixture
framework can be used to predict classes of individuals. For our real-life applica-
tion, this means being able to decide whether HIV patients are non-responders,
responders, rebounders or some mixture of the above. For BSMM, the latent cate-
gorical covariate z contains the unknown “class” labels that need to be estimated.
For a given set of population parameters θ, we can use each individual’s conditional
distribution p(zi, ψi|yi, θ) to estimate the latent variable zi and the vector of indi-
vidual parameters ψi. A first estimate is the Maximum a Posteriori (MAP) which is
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obtained by maximizing this joint conditional distribution with respect to (zi, ψi):(
zˆi, ψˆi
)
= arg max
(zi,ψi)
p (zi, ψi|yi, θ) .
This maximization is not straightforward and we refer the reader to [11] for
a complete methodology. Another way to estimate the latent covariate zi is to
maximize the marginal conditional distribution:
zˆi = arg max
m
P (zi = m|yi; θ) . (5)
The value of (5) can be estimated using a stochastic approximation during the
SAEM iterations.
As for WSMM, since there are no latent categorical covariates z, estimation of
individual proportions pii as well as individual parameters ψi is straightforwardly
obtained by maximizing the joint conditional distribution p (pii, ψi|yi, θ) with respect
to (pii, ψi): (
pˆii, ψˆi
)
= arg max
(pii,ψi)
p (pii, ψi|yi, θ) .
Once we have estimates of individual parameters, individual predictions for
BSMM are obtained using yˆij = fzˆi
(
xij , ψˆi
)
. Similarly, for WSMM, the individual
predictions are calculated as
yˆij =
M∑
m=1
pˆiimfm
(
xij , ψˆi
)
.
4. SIMULATED DATA EXAMPLE
4.1. Modeling with Between-Subject Model Mixtures
We performed a simulation study to evaluate the performance of the proposed
BSMM algorithm for estimating parameters and classifying individuals using a mix-
ture of two simple models defined as follows:
if zi = 1, yij = f1 (ψi, tij) + aεij
if zi = 2, yij = f2 (ψi, tij) + aεij ,
where
f1 (ψi, tij) = Ai , f2 (ψi, tij) = Aie
−Litij ,
and the vectors of individual parameters ψi = (log(Ai), log(Li)) are such that Ai
and Li are log-normally distributed, log(Ai) ∼ N
(
log(A), σ2A
)
and log(Li) ∼
N (log(L), σ2L). Note that this model can also be seen as a parameter mixture
for Li: Li = 0 in group 1 and Li log-normally distributed in group 2. For the
experiments, we set A = 10, L = 0.2, σ2A = 0.5 and σ
2
L = 0.5. Furthermore, we
fixed P (zi = 1) = pi1 = 1/3 and a = 1. tij is the jth measurement time for
subject i, and we used the same set of times t = 0, 1, . . . , 8 for all N subjects.
K = 1000 datasets were simulated and the parameters were estimated using the
proposed algorithm. Figure 1 shows examples of longitudinal data for 10 subjects
with (a) zi = 1 and (b) zi = 2.
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Figure 1
Spaghetti Plots of Data for Ten Individuals Belonging to
Group 1 (a) and 10 Others Belonging to Group 2 (b).
Figure 2
Empirical Distribution of the Relative Estimation Error
(REEk (%)) in the BSMM Scenario with Different Sample
Sizes: (a-d) N = 100, (e-h) N = 1000 and Various Cases:
(a)&(e) z and ψ Are Known, (b)&(f) z Is Unknown and ψ
Is Known, (c)&(g) z Is Known and ψ Is Unknown, (d)&(h)
z and ψ Are Unknown. The Estimated Parameters Are 1:
pi1; 2: A; 3: L; 4: σ
2
A; 5: σ
2
L; 6: a.
Let θ? be the true value of any parameter and θˆk the estimated value obtained
with the kth simulated dataset. The relative estimation error (in %) REEk was
used as a quality criteria:
REEk =
θˆk − θ?
θ?
× 100.
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Figure 2 shows the distribution of the REEk for each parameter when (a-d)
N = 100 and (e-h) N = 1000 with various experimental situations, i.e., when ψ
and/or z are supposed known/unknown.
It suggests that most parameters are estimated with little or no bias, except
perhaps the variance of the individual parameter Li. Cases (a-b) and (e-f) are quite
similar, suggesting that the EM algorithm is efficient with respect to bias (mixture
parameters are estimated in cases (b-f) with the EM algorithm). Furthermore, cases
(c-d) and (g-h) are quite similar and we see that there is little degradation compared
with (a-b) and (e-f) respectively. Thus, the SAEM algorithm for mixtures appears
to be efficient with respect to bias. As expected, we see that parameters are better
estimated with N = 1000, but even with N = 100 the results are acceptable.
Quantitative results are presented in Table 1, which gives means as well as
standard errors for each of the estimated parameters when N = 100 and N = 1000.
Table 1
Mean of Parameter Estimates and Standard Errors for the
BSMM Scenario with N = 100 or N = 1000.
N=100 N=1000
θ θ∗ Mean of estimates SE of θˆ Mean of estimates SE of θˆ
pi1 0.33 0.334 0.049 0.331 0.015
A 10 10.03 0.713 10.01 0.226
L 0.20 0.202 0.02 0.20 0.006
σ2A 0.50 0.497 0.075 0.50 0.023
σ2L 0.50 0.49 0.099 0.50 0.033
a 1 1.004 0.026 1.002 0.008
The parameter estimates, overall, match the population values, and the stan-
dard errors seems reasonable and are quite low, especially with large sample size.
In addition, Figure 3, representing the relative difference between the estimated
standard error and the empirical standard error, shows that the standard errors are
well estimated and match quite well the empirical ones.
Figure 3
Relative Difference (in %) Between Estimated and
Empirical Standard Errors for the BSMM Scenario with
(a): N = 100, (b): N = 1000. The Estimated Parameters
Are 1: pi1; 2: A; 3: L; 4: σ
2
A; 5: σ
2
L; 6: a.
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Figure 4 provides a graphical illustration of the probability of correct classifica-
tion in both groups for N = 100 and N = 1000 subjects. Note that the number of
individuals in each group is considered as fixed here (N1 = Npi1) during the Monte
Carlo simulation. For each of the K = 1000 runs, the probabilities of correct clas-
sification for the N subjects were computed and ranked in increasing order. Then,
the empirical median sequence of these 1000 sequences was computed in each group.
This median is represented by the solid line in Figure 4. These graphs are more
informative than the distribution of the number of subject misclassified over the
simulations. Indeed, we see for instance that, with N = 100, less than 3 (resp. 4)
subjects among 33 (resp. 67) of group 1 (resp. group 2) have a probability smaller
than 0.8 to be correctly classified in half of the cases.
As expected, the probability of correct classification is greater when (ψi) is
known, but it is interesting to note that the difference is relatively small.
Figure 4
Medians of the Probabilities of Correct Classification
Ranked in Increasing Order in Both Groups with (a & b):
N = 100 (N1 = 33, N2 = 67) and (c & d): N = 1000
(N1 = 333, N2 = 667) Subjects ; (a & c): Group 1 and (b &
d): Group 2. Solid Line: the Individual Parameters (ψi)
Are Unknown; Dotted Line: the Individual Parameters (ψi)
Are Known.
4.2. Modeling with Within-Subject Mixture Models
We used the same model but now assumed that individual proportions pii1 were
model parameters:
f (ψi, tij) = pii1f1 (ψi, tij) + (1− pii1)f2 (ψi, tij) ,
where the structural models f1 and f2 were the same as for those for the BSMM,
and individual proportions modeled as:
pii1 =
1
1 + s eηi
, ηi ∼ N
(
0, σ2s
)
,
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with s = 2 and σ2s = 0.2. Population parameters were fixed at A = 10, L = 0.2, σ
2
A =
0.5 and σ2L = 0.5. We used the same measurement times for the N subjects as in
the BSMM scenario.
Figure 5 shows the distribution of the REEk for each parameter (a & b) and the
relative difference between the estimated standard error and the empirical standard
error (c & d), when (a & c): N = 100 and (b & d): N = 1000 subjects.
Figure 5
Empirical Distribution of the Relative Estimation Error
(REEk (%)) in the WSMM Scenario (a & b) and the
Relative Difference Between the Estimated Standard Error
and the Empirical Standard Error (c & d) with Two Sample
Sizes: (a & c): N = 100, and (b & d): N = 1000. The
Estimated Parameters Are 1: s; 2: A; 3: L; 4: σ2s ; 5: σ
2
A; 6:
σ2L; 7: a.
We see in (a) and (b) that parameters are estimated with very little bias, and
with high precision when the sample size increases to N = 1000. In (c) and (d), we
see that the standard errors are generally well estimated and close to the empirical
ones when the sample size increases to N = 1000.
Quantitative results are presented in Table 2, which gives means as well as the
standard errors for each of the estimated parameters when N = 100 and N = 1000.
The parameter estimates, overall, match the population values and the standard
errors seem reasonable and are quite small with large sample size.
5. APPLICATION TO REAL DATA
5.1. Description of the Data
The randomized, controlled and partially blinded POWER project conducted by
TIBOTEC comprises 3 studies performed in highly treatment-experienced HIV-
infected patients using Darunavir/Ritonavir or an investigator-selected control pro-
tease inhibitor, combined with an optimized background regimen of nucleotide re-
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Table 2
Mean of Parameter Estimates and Standard Errors for the
WSMM Scenario with N = 100 or N = 1000.
N=100 N=1000
θ θ∗ Mean of estimates SE of θˆ Mean of estimates SE of θˆ
s 2 2.02 0.2183 2.00 0.053
A 10 10.04 0.714 10.00 0.226
L 0.20 0.202 0.021 0.199 0.006
σ2s 0.20 0.212 0.11 0.205 0.022
σ2A 0.50 0.495 0.073 0.50 0.023
σ2L 0.50 0.481 0.112 0.50 0.032
a 1 1.00 0.027 1.00 0.008
verse transcriptase inhibitors with or without the fusion inhibitor enfuvirtide. The
output data is the viral load evolution for 578 patients. Figure 6 gives examples of
patients with one of three “characteristic” viral load progressions:
• Non-responders (1) show no decline in viral load.
• Responders (2) exhibit a sustained viral load decline.
• Rebounders (3 and 4) exhibit an initial drop in viral load, then a rebound to
higher viral load levels.
Figure 6
Viral Load Progression for 4 HIV-Infected Patients. (1)
Non-Responder; (2) Responder; (3) and (4) Are
Rebounders. Red Points Indicate Below Level of
Quantification Data.
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Remark. There is a detection limit at 50 HIV RNA copies/ml, corresponding
to a log-viral load of 1.7; i.e., data are left censored. These points are shown in red
in Figure 6. Censoring is taken into account in the following analysis as described
in [17].
5.2. Class Prediction Using Between-Subject Model Mixtures
Within a few months of HIV infection, patients typically enter a steady state of
chronic infection and have a stabilized concentration of HIV-1 in blood plasma.
When the anti-retroviral treatment starts, the viral load of patients who respond
shows an initial rapid exponential decay, usually followed by a slower second phase
of exponential decay, see [14]. It is shown in [5] that the biphasic decay in viral load
can be approximated by a bi-exponential model A1e
−λ1t +A2e−λ2t.
After the decrease in viral load levels, some subjects show a rebound, which can
be due to several factors (non-adherence to the therapy, emergence of drug-resistant
virus strains, etc.). We propose to extend the bi-exponential model to these patients
by adding a third phase described by a logistic growth process A3/(1 + e
−λ3(t−τ)),
where τ is the inflection point of this growth process.
We then propose to describe the log-transformed viral load with a BSMM with
three simple models, corresponding to each of three characteristic viral load pro-
gressions:
• Non-responder-like data can be described using a simple horizontal line. The
structural model is given by:
zi = 1, f1 (ψi, tij) = A1i +A2i .
• As described above, the drop in viral load in responder-like data can be de-
scribed using a bi-exponential mixed-effects model:
zi = 2, f2 (ψi, tij) = A1ie
−λ1itij +A2ie−λ2itij ,
where λ1i and λ2i describe the rate of exponential decay and A1i and A2i
are intercept parameters for individual i. As in [3], these parameters are
considered to be strictly positive.
• Rebounder-like data show a rebound after a biphasic decrease in viral load
levels:
zi = 3, f3 (ψi, tij) = A1ie
−λ1itij +A2ie−λ2itij +
A3i
1 + e−λ3i(tij−τi)
.
The log-transform viral load is then modeled by:
log (yij) =
3∑
m=1
1zi=m log (fm (ψi, tij)) + εij , (6)
where yij is the viral load for subject i at time tij and ψi = (A1i, A2i, A3i, λ1i, λ2i,
λ3i, τi) the vector of individual parameters.
These parameters are positive and distributed according to log-normal distribu-
tions. Thus,
logAli = logAl + ηli, ηli ∼ N
(
0, σ2Al
)
, l = 1, 2, 3
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log λmi = log λm + η(m+3) i, η(m+3) i ∼ N
(
0, σ2λm
)
, m = 1, 2, 3
log τi = log τ + η7i, η7i ∼ N
(
0, σ2τ
)
.
By setting pi1 = P (zi = 1), pi2 = P (zi = 2) and pi3 = P (zi = 3) with
∑3
m=1 pim =
1, the complete set of population parameters to be estimated is given by θ =
(A1, A2, A3, λ1, λ2, λ3, τ, pi1, pi2, pi3).
Parameter estimation was performed using the SAEM algorithm for BSMM
implemented in Monolix. This algorithm combined with a previous version [17]
(which is an extension of the SAEM algorithm [8] to left censored data) takes
properly into account the censored viral load data below the limit of quantification.
Figure 7 shows the individual fits for the 4 patients, the vector of estimated posterior
probabilities pˆi where pim = P
(
zi = m|yi; θˆ
)
, i.e., the probabilities for each subject
to belong to each of the three classes, and the class zi to which they are assigned
(1 = non-responder, 2 = responder, 3 = rebounder) corresponding to the maximum
of the estimated posterior probabilities. We see that in all four cases, there is little
ambiguity in the results, i.e., the correct class has a posterior probability very close
to 1.
Figure 7
Viral Load Time Series and Individual Fits for the Four
Patients in Figure 6. zi is the Predicted Class of the Patient
(1 = Non-Responder, 2 = Responder, 3 = Rebounder) and
pi the Posterior Probability that the Patient Is in Classes 1
to 3; the Index of Its Maximum Component Is Used to
Predict zi.
5.3. Class Prediction Using Within-Subject Mixture Models
Not all observed viral load progressions fall so easily into one of the three classes,
as for example the patients shown in Figure 8.
162
Mbogning, C., Bleakley, K., & Lavielle, M./Progress in Applied Mathematics,
4 (2), 2012
Figure 8
Viral Load Data for 4 Patients with Ambiguous
Progressions. Red Points Indicate Below Level of
Quantification Data.
Figure 9
Viral Load Time Series and Individual Fits for Patients 5–8
from Figure 8 When Using BSMM (row 1) and WSMM
(row 2). For BSMM, zi Is the Predicted Class of the Patient
(1 = Non-Responder, 2 = Responder, 3 = Rebounder) and
pi the Posterior Probability that the Patient Is in Classes 1
to 3. For WSMM, pi Are the Mixture Parameters of the
Classes Estimated as Part of the Model.
In these cases, it does not seem quite so reasonable to model the data under the
BSMM assumption that each patient must belong uniquely to one class; instead,
it is perhaps more natural to suppose that each patient is partially responding,
partially non-responding and partially rebounding with respect to the given drug
treatment. The goal becomes to find the relative strength of each process in each
patient, and a WSMM is an ideal tool to do this. The proportions pii are now
individual parameters in the model and the problem is transformed into a standard
NLMEM. Since these proportions are assumed to be positive and summing to 1
for each patient, we assumed a logit-normal distribution on the piim,m = 1, 2, 3 as
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follows:
pii1 =
γ1i
1 + γ1i + γ2i
pii2 =
γ2i
1 + γ1i + γ2i
pii3 =
1
1 + γ1i + γ2i
,
with
log γki = log γk + ηki, ηki ∼ N
(
0, σ2γk
)
for k = 1, 2.
We performed parameter estimation for WSMM using the SAEM algorithm in
Monolix, taking properly into account the censored viral load data below the limit
of quantification as before. Results for the four patients are presented in Figure 9;
the first row gives the results which would be obtained using BSMM for these four
patients, the second row the WSMM results.
We see that for all four patients, BSMM predicts that the patient was a respon-
der. The visually poor individual fits in all four cases give rise to suspicion in the
validity of the result. In particular, in plot 8 – top row – what appears to be a
“late” rebounder is hardly “seen” by the algorithm; the posterior probability that
the patient is a rebounder is only 0.085. Clearly, forcing each patient to belong
to one class in the interior of the algorithm is a disadvantage of the method for
real-world data.
In contrast to this, the first thing that is immediately obvious with the WSMM
modeling (Figure 9 – bottom row) is that the individual fits are significantly better
than the BSMM ones. This can be confirmed using the BIC criteria which clearly se-
lects the WSMM model: BIC(WSMM)=14668, whereas BIC(BSMM)=15029. The
estimated parameters pi are generally consistent with what we “see” in the graphs,
and when they are not, it helps us to look closer.
For instance, in plots 5 and 6 – bottom row – we see evidence of responding
and a hint of rebound; this is confirmed in the estimated parameters pi. In plot 7
– bottom row – the patient would seem to be a very slowly-but-surely responder.
However, modeling happens population-wise, and this patient’s reponder curve is
far from the “normal” (steep drop followed by flatlining) responder; consequently
the responder proportion in the mixture is small (0.088). Another reason may be
that the 4th, 5th and 6th data points indicate a steep rebound from the 3rd data
point (even though subsequent points drop) possibly influencing the weight of the
rebounder model in the mixture (0.613). This is probably also accentuated by
the fact that the rebounder model “includes” the responder model’s biexponential
decay terms. This remark also goes some way to explaining plot 8 – bottom row;
the rebounder mixture coefficient (0.580) dominates and the responder coefficient
(0.059) is unintuitively small. Again this is probably because the steep drop that
we associate with the responder model is already included as the first two terms in
the rebounder model; hence the small responder coefficient.
6. DISCUSSION
We have presented a classification methodology to interpret longitudinal data in a
population context using model mixtures in the NLMEM framework. Two classes
of model mixtures were introduced: between-subject and within-subject (BSMM
and WSMM), and it was shown how to perform maximum likelihood estimation
in the BSMM case. These algorithms are now available in the software Monolix.
In simulations with mixtures of two models, we saw generally good parameter es-
timation performance and prediction performance, i.e., prediction of which model
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had been used to generate each individual’s longitudinal data. In real longitudinal
HIV viral load data, we found that BSMMs were very efficient both in modeling
and predicting the type of patient (non-responder, responder, rebounder) whenever
the patient’s viral load evolution was a “model case” of one of the three classes.
However, when the viral load evolution was not so “typical”, the fact that BSMMs
force the allocation of once class to each patient lead to poor individual model fits
and what’s more, dubious class prediction.
On the other hand, WSMMs allow for more flexibility in modeling and are
consistent with the biologically plausible hypothesis that each individual may be
only partially responding/non-responding/rebounding due to their own unique virus
strains, cell populations, etc. Allowing a mixture of biologically relevant models
internally to each patient clearly improved the individual model fits and permitted
a more nuanced reply to the classification question of whether the patient was
responding adequately to the treatment or not. Based on these results, we would
have more confidence in suggesting a modification to HIV drug regimes based on
WSMM modeling than BSMM.
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